Treatment of hyperlipemia and hypertriglyceridemia

Details Treatment of hyperlipemia and hypertriglyceridemia Treatment of hyperlipemia and hypertriglyceridemia

1992-12-09

1994-06-21

Brown, Johnnie R.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

536 2762, A61K 3170, C07H 19067

Patent

active

053228405

ABSTRACT:
The object of the present invention is the administration of a substance which contains, as active principle, an adenosine substituted on N.sup.6 of formula I ##STR1## in which R.sub.1, R.sub.2 and R.sub.3 each represents hydrogen or ##STR2## for the treatment of hyperlipemia and/or hypertriglyceridemia.

REFERENCES:
patent: 4906620 (1993-04-01), Laborit et al.
Bonifacj et al., "Action of N.sup.6 -(amido-3-propyl) adenosine hydrochloride (Agr 529) on Plasma Corticosterone Levels in Rats," Res. Comm. Chem. Pathol. Pharmacol., 68(3), 299-305 (1990); Medline Abstract 07442911, File 155, Dialog Info. Serv.); Only abstract supplied.
Laborit et al., "Changes in Plasma Cathecholamine Levels After the Intraperitoneal and Intracerebroventicular Administration of Adenosine Analogs and of Clonidine in Conscious Rats," Res. Comm. Chem. Pathol. Pharmacol., 68(3), 307-327 (1990); Medline Abstract 07442912, File 155, Dialog Info. Serv.); Only abstract supplied.

Affiliated with

Also associated with

Rating

Treatment of hyperlipemia and hypertriglyceridemia does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of hyperlipemia and hypertriglyceridemia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of hyperlipemia and hypertriglyceridemia will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2220752